Table 1 Descriptive statistics of Swedish patients and tumor sets.
From: Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort
Characteristics | Patient % (count) |
|---|---|
PATIENTS | |
Age | |
Mean age (years) | |
67.4 | |
Range (years) | |
43–96 | |
Group | |
< 70 years | 62% (38) |
> 70 years | 38% (23) |
Ancestry | |
European | 100% (61) |
Site | |
Primary | 100%(61) |
Treatment | |
No neoadjuvant | 100%/61) |
TUMORS | |
Hormone-receptor | |
ER + | 85% (52) |
PR + | 77% (47) |
HER2 + | 11%(7) |
ER + /PR + | 66% (40) |
ER-/PR-/HER2- | 3% (2) |
Histopathology | |
Lobular | 7% (4) |
Ductal | 92% (56) |
Ductal-in situ | 13% (8) |
Tumor fraction | |
< 50% | 18% (11) |
51–60% | 30% (18) |
61–70% | 22% (14) |
71–85% | 30% (18) |
